Patents by Inventor George Campbell Kaynor

George Campbell Kaynor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • JCV neutralizing antibodies
    Patent number: 9567391
    Abstract: In one aspect, the disclosure provides neutralizing antibodies against JCV and methods for the treatment of PML. In some embodiments, aspects of the invention relate to an isolated JC-virus neutralizing monoclonal antibody against JCV capsid protein VPI (JCV-VP1). In some embodiments, the antibody suppresses infectivity of the JC-virus. In some embodiments, the antibody binds the sialic acid binding pocket of JCV-VPI. In some embodiments, the antibody binds JCV-VP 1 comprising one or more of the following mutations: S269F, S269Y, S267F, N265D, Q271 H, D66H, K60E, K60N and L55F.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: February 14, 2017
    Assignee: Biogen MA Inc.
    Inventors: Kenneth Simon, Thomas Cameron, Mia Rushe, Justin Caravella, George Campbell Kaynor
  • JCV NEUTRALIZING ANTIBODIES
    Publication number: 20150056188
    Abstract: In one aspect, the disclosure provides neutralizing antibodies against JCV and methods for the treatment of PML. In some embodiments, aspects of the invention relate to an isolated JC-virus neutralizing monoclonal antibody against JCV capsid protein VPI (JCV-VP1). In some embodiments, the antibody suppresses infectivity of the JC-virus. In some embodiments, the antibody binds the sialic acid binding pocket of JCV-VPI. In some embodiments, the antibody binds JCV-VP 1 comprising one or more of the following mutations: S269F, S269Y, S267F, N265D, Q271 H, D66H, K60E, K60N and L55F.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 26, 2015
    Applicant: Biogen Idec MA Inc.
    Inventors: Kenneth Simon, Thomas Cameron, Mia Rushe, Justin Caravella, George Campbell Kaynor